Soleno Therapeutics Inc News - SLNO | Aktien NASDAQ | ADVFN

Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

Soleno Therapeutics Inc (SLNO)

49,11

0,71

(1,47%)

Geschlossen 23 März 9:00PM

Verzögert um 15 Minuten

49,11

0,04

(0,08%)

Nach Börsenschluss: 10:30PM

Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results

REDWOOD CITY, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Soleno Therapeutics to Participate in Upcoming February Investor Conferences

REDWOOD CITY, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Foren

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Soleno Therapeutics

Eurobank Ergasias Services

BNP Paribas Issuance

Anheuser Busch InBev

Alaris Equity Partners (PK)

Sailfish Royalty

Development Bank of Japan

Vontobel Financial Produ...

ThermoGenesis (CE)

Bmo Short Provincial BD (GM)

Reserve Bank of NZ Offic...

Tribe Property Technolgies

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen